Bureaucratic Mismanagement? USDA Spent $2 Million an Intern

Aug 10, 2012

The USDA is in hot water over a funding project that went wrong. USDA officials had spent $2 million on an internship program and only had one participating intern. This issue occurred because the department failed to protect themselves from hackers, even after receiving $63 million in federal government towards boosting security measures.

This cover-up scandal was revealed after a USDA inspector report found that the Office of Chief Information Officer had “funded an intern program for a total of $2 million which, while funded as a security enhancement project, only resulted in one intern being hired full-time for ASOC [Agriculture Security Operations Center.”

This oversight sheds some light on USDA’s mismanagement of 16 projects that were supposed to protect the department from security threats. Back in 2009 the department requested an increase to the security budget from $18 million to $44 million. The stickler in the report is that even after an increase of $63.4 million in overall funding, the department received back in 2010 and 2011, however, the IT and security systems are still susceptible to risk. This sounds like a case of bureaucratic mismanagement at its best.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.